These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2466490)

  • 41. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
    Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
    Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seasonality of cerebrospinal fluid monoamine metabolite concentrations and their associations with meteorological variables in humans.
    Brewerton TD; Putnam KT; Lewine RRJ; Risch SC
    J Psychiatr Res; 2018 Apr; 99():76-82. PubMed ID: 29427844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous determination of DOPAC, MHPG, 5-HIAA and HVA in CSF by direct injection on a liquid chromatograph with coulometric detection.
    d'Eril GV; Rizzo V; Cellerino GP
    Funct Neurol; 1990; 5(2):145-9. PubMed ID: 1699850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
    Jibson M; Faull KF; Csernansky JG
    Biol Psychiatry; 1990 Oct; 28(7):595-602. PubMed ID: 1699614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid monoamine metabolite levels in human newborn infants born in winter differ from those born in summer.
    Chotai J; Murphy DL; Constantino JN
    Psychiatry Res; 2006 Dec; 145(2-3):189-97. PubMed ID: 17074397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
    Pech J; Forman J; Kessing LV; Knorr U
    J Affect Disord; 2018 Nov; 240():6-16. PubMed ID: 30041075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
    Cooper SJ; Leahey W; Green DF; King DJ
    Br J Psychiatry; 1988 Jan; 152():59-63. PubMed ID: 2458796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ; Swedo SE; Hamburger SD; Potter WZ; Rapoport JL
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
    Kawakami M; Itoh T
    Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.
    Wieselgren IM; Lindström LH
    Psychiatry Res; 1998 Nov; 81(2):101-10. PubMed ID: 9858027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
    Hildebrand J; Bourgeois F; Buyse M; Przedborski S; Goldman S
    Acta Neurol Scand; 1990 May; 81(5):427-30. PubMed ID: 1695809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression.
    Fu R; Jinnah H; Mckay JL; Miller AH; Felger JC; Farber EW; Sharma S; Whicker N; Moore RC; Franklin D; Letendre SL; Anderson AM
    J Neurovirol; 2023 Aug; 29(4):440-448. PubMed ID: 37289360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
    Maas JW; Kocsis JH; Bowden CL; Davis JM; Redmond DE; Hanin I; Robins E
    Psychol Med; 1982 Feb; 12(1):37-43. PubMed ID: 6177015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.